Linagliptin. Cas No: 668270-12-0

CAS668270-12-0

Linagliptin is indicated for the treatment of type II diabetes in addition to diet and exercise It should not be used to treat type I diabetes or in diabetic ketoacidosis. An extended-release combination product containing empagliflozin, linagliptin

Chemical formula :C25H28N8O2

Linagliptin is a competitive, reversible DPP-4 inhibitor. Inhibition of this enzyme slows the breakdown of GLP-1 and glucose-dependant insulinotropic polypeptide (GIP)